Addressing Critical Needs Globally
DEERFIELD, Ill., April 10, 2014 /3BL Media/ – Baxter International Inc. (NYSE: BAX) and its philanthropic arm, The Baxter International Foundation, make financial and in-kind donations to address critical community needs globally, including increasing access to healthcare, improving education and helping developing nations and countries in crisis. In 2013, combined giving from Baxter and its Foundation totaled more than $64 million, composed of:
- More than $34 million from donations of Baxter products through donor partners and the company's U.S. patient assistance programs. Product donations helped 81 countries in need, including proactive donations for Typhoon Haiyan relief in the Philippines. Pre-positioning product helps Baxter ensure its critical products are first on the scene following disasters and tragedies, and that the company is contributing the most needed products to stabilize supply in developing economies and meeting ongoing needs in underserved communities.
- More than $27 million from Baxter's businesses and facilities to address critical local needs in more than 42 countries.
- Nearly $3 million from The Baxter International Foundation, including grants to increase access to healthcare worldwide, prize programs that recognize excellence in community service and healthcare research, a scholarship program that contributes to the education of Baxter employees' children, and support of employees' philanthropic efforts through the Foundation's Dollars for Doers and Matching Gifts programs. A full listing of The Baxter International Foundation grants awarded in 2013 is available at www.baxter.com/grants.
Baxter's commitment to sustainability spans more than three decades. The company is included in the Dow Jones Sustainability Index and has been recognized by Corporate Responsibility magazine as one of the 100 Best Corporate Citizens and Newsweek’s Green Rankings as a leading U.S. healthcare company. Baxter is a member of the Center for Health and the Global Environment at Harvard School of Public Health, Center for Corporate Citizenship at Boston College, and the Ethics & Compliance Officer Association. The company endorses the Ceres principles and is an Organizational Stakeholder of the Global Reporting Initiative. Further information about Baxter’s sustainability activities can be found at www.sustainability.baxter.com.
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
# # #